LicenseTheData.comA field guide to business-data licensing
Home/Comparisons

Public evidence · 13 October 2026

Appen vs Turing Project Lazarus

Direct licensing meets direct licensing. Neither advertised amounts nor a public seller route establish what your business will receive.

Jump to the terms ledger ↓

Research comparison; limited public terms. Pair-level evidence and scenario review is pending. Published fields alone do not meet our indexing threshold. This page is noindex and absent from the sitemap, not a negative verdict.

The terms ledger.

Headquarters or contact location is not seller eligibility. Response, acceptance and payout stages are not interchangeable.

Published descriptions and unresolved contract terms
CriterionAppenTuring Project Lazarus
Operating recordsPublished
SOPs, wikis, approval chains, support/ITSM/CRM, ERP, messaging, BI, contracts, HR/payroll
Source ↗
Published
Communications, tickets, wikis, databases and code; code not required and not bought alone
Source ↗
Company eligibilityPublished
Operating or winding-down companies; no size minimum published.
Source ↗
Published
Any company with real operating history and an authorized representative; operating, winding-down or closed.
Source ↗
Seller geographyUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Published
Most regions; strongest demand US/UK/Canada/EU; export restrictions apply.
Source ↗
Published compensationProvider claim
Individually quoted by rarity, structure and history.
Source ↗
Provider claim
Single payout up to $1M; USD context; not recurring royalties or a guaranteed offer.
Source ↗
Fees & net proceedsPublished
No costs, setup fees or deductions.
Source ↗
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Timeline & payment triggerProvider claim
Payment on acceptance; two-business-day response is not a payout deadline.
Source ↗
Provider claim
Intake call within one business day; valuation usually within a week of access. Neither is a payout deadline.
Source ↗
Preparation & seller effortPublished
Register → NDA → written scope → extraction → representative sample sign-off → license.
Source ↗
Published
NDA → intake → representative sampling/valuation → one contract.
Source ↗
Ownership & permitted usePublished
Retains ownership.
Source ↗
Published
Retains underlying ownership; defined rights to prepared record.
Source ↗
Privacy & approvalProvider claim
Read-only encrypted isolated pipelines; anonymization or synthetic rewrites; buyers/third parties do not see raw data; retention/deletion agreed before extraction.
Source ↗
Provider claim
Named team, scoped access, air-gapped processing; personal data/secrets removed before model use. SOC 2 Type II claimed.
Source ↗
ExclusivityUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Retention & deletionPublished
Retention/deletion follow agreed terms; no public exact duration.
Source ↗
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
HQ / published contactPublished
Corporate HQ Sydney, Australia; US HQ Kirkland, Washington, according to program page.
Source ↗
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

Operating records

AppenPublished
SOPs, wikis, approval chains, support/ITSM/CRM, ERP, messaging, BI, contracts, HR/payroll
Source ↗
Turing Project LazarusPublished
Communications, tickets, wikis, databases and code; code not required and not bought alone
Source ↗

Company eligibility

AppenPublished
Operating or winding-down companies; no size minimum published.
Source ↗
Turing Project LazarusPublished
Any company with real operating history and an authorized representative; operating, winding-down or closed.
Source ↗

Seller geography

AppenUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Turing Project LazarusPublished
Most regions; strongest demand US/UK/Canada/EU; export restrictions apply.
Source ↗

Published compensation

AppenProvider claim
Individually quoted by rarity, structure and history.
Source ↗
Turing Project LazarusProvider claim
Single payout up to $1M; USD context; not recurring royalties or a guaranteed offer.
Source ↗

Fees & net proceeds

AppenPublished
No costs, setup fees or deductions.
Source ↗
Turing Project LazarusUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

Timeline & payment trigger

AppenProvider claim
Payment on acceptance; two-business-day response is not a payout deadline.
Source ↗
Turing Project LazarusProvider claim
Intake call within one business day; valuation usually within a week of access. Neither is a payout deadline.
Source ↗

Preparation & seller effort

AppenPublished
Register → NDA → written scope → extraction → representative sample sign-off → license.
Source ↗
Turing Project LazarusPublished
NDA → intake → representative sampling/valuation → one contract.
Source ↗

Ownership & permitted use

AppenPublished
Retains ownership.
Source ↗
Turing Project LazarusPublished
Retains underlying ownership; defined rights to prepared record.
Source ↗

Privacy & approval

AppenProvider claim
Read-only encrypted isolated pipelines; anonymization or synthetic rewrites; buyers/third parties do not see raw data; retention/deletion agreed before extraction.
Source ↗
Turing Project LazarusProvider claim
Named team, scoped access, air-gapped processing; personal data/secrets removed before model use. SOC 2 Type II claimed.
Source ↗

Exclusivity

AppenUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Turing Project LazarusUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

Retention & deletion

AppenPublished
Retention/deletion follow agreed terms; no public exact duration.
Source ↗
Turing Project LazarusUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

HQ / published contact

AppenPublished
Corporate HQ Sydney, Australia; US HQ Kirkland, Washington, according to program page.
Source ↗
Turing Project LazarusUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

Which difference matters to your company?

Data fit

For your existing records, start with category fit: Appen lists SOPs, wikis, approval chains, support/ITSM/CRM, ERP, messaging, BI, contracts, HR/payroll; Turing Project Lazarus lists Communications, tickets, wikis, databases and code; code not required and not bought alone. Ask each which subset has active demand before preparing exports.

Appen: source 1 ↗ Turing Project Lazarus: source 1 ↗ Public descriptions, not tested seller outcomes.

Payment trigger

Appen: Payment on acceptance; two-business-day response is not a payout deadline. Turing Project Lazarus: Intake call within one business day; valuation usually within a week of access. Neither is a payout deadline. These clocks measure different stages, not equivalent payout deadlines; ask for a written acceptance-to-payment interval.

Appen: source 1 ↗ Turing Project Lazarus: source 1 ↗ Public descriptions, not tested seller outcomes.

Shared diligence, not shared guarantees.

Both routes need lawful rights to the material. Removing names does not remove confidentiality obligations or re-identification risk. Require sample approval, buyer-use restrictions, precise payment triggers and downstream retention/deletion terms.

Seller-outcome evidence

Appen: No independently audited operating-business payout established in this research. Provider cases and partnership confirmations do not establish a typical seller outcome.

Turing Project Lazarus: No independently audited operating-business payout established in this research. Provider cases and partnership confirmations do not establish a typical seller outcome.

Put two routes side by side.

Choose two different providers. No income ranking.

Sources & unknowns.

Source claims were inspected on 13 October 2026. No intake was submitted or transaction tested. Unknowns are not zero fees, universal eligibility or unrestricted rights.

Read the evidence and indexing methodology →